The Russian Union of Industrialists and Entrepreneurs highly appreciated Promomed Group of Companies

Promomed Group won the competition of the Russian Union of Industrialists and Entrepreneurs in the nomination "For dynamic business development".

By the end of 2022, the company's production volume amounted to more than 80 million packages of medicines for various purposes. New production facilities have been commissioned at the Biochemik plant, the company's production site, which will allow the production of one billion tablets per year, as well as one of the country's largest pharmaceutical substance production facilities with a capacity of 340 tons per 150 types of substances. The company's portfolio currently includes more than 250 medicines, and another 190 items are at various stages of development and registration.

"The victory in the Russian Union of Industrialists and Entrepreneurs' All–Russian competition "Russian Business Leaders: Dynamics, Responsibility, Sustainability - 2022" is a well-deserved and worthy assessment of the activities of the entire Promomed Group team by the professional expert community. Applications were submitted by 287 participants from all over the country. It is doubly gratifying to receive such an assessment in the current difficult time. This once again shows the united team spirit and the ability to be united in meeting the company's development goals," said Mikhail Avramenko, Director of Work with Government Agencies.

The most important strategic direction in the work of Promomed is the solution of significant medical problems, saving and significantly improving the quality of life. For many years, the drugs produced by the company have been helping thousands of patients in the fight against a wide variety of diseases. More than 80 percent of these medicines are included in the list of essential and essential medicines (VED).